1)Benamer HT, Bone I:Cerebral venous thrombosis:anticoagulants or thrombolytic therapy. J Neurol Neurosurg Psychiatry 69:427-430, 2000
2)Bousser MG:Cerebral venous thrombosis:nothing, heparin, or local thrombolysis? Stroke 30:481-483, 1999
3)Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F;ISCVT Investigators:Causes and predictors of death in cerebral venous thrombosis. Stroke 36:1720-1725, 2005
4)Carhuapoma JR, Mitsias P, Levine SR:Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 28:2363-2369, 1997
5)Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F;ISCVT Investigators:Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 36:1927-1932, 2005
6)Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F;ISCVT Investigators:Prognosis of cerebral vein and dural sinus thrombosis:results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664-670, 2004
7)Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK:Cerebral venous thrombosis:combined intrathrombus rtPA and intravenous heparin. Stroke 30:489-494, 1999
8)Girot M, Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, Leys D;ISCVT Investigators:Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 38:337-342, 2007
9)Kuwahara S, Abe T, Uga S, Mori K:Superior sagittal sinus and cerebral cortical venous thrombosis caused by congenital protein C deficiency--case report. Neurol Med Chir (Tokyo) 40:645-649, 2000
10)Nagai S, Horie Y, Akai T, Takeda S, Takaku A:Superior sagittal sinus thrombosis associated with primary antiphospholipid syndrome--case report. Neurol Med Chir (Tokyo) 38:34-39, 1998
11)van Gijn J:Cerebral venous thrombosis:pathogenesis, presentation, and prognosis. J R Soc Med 93:230-233, 2000
12)Vogl TJ, Bergman C, Villringer A, Einhäupl K, Lissner J, Felix R:Dural sinus thrombosis:value of venous MR angiography for diagnosis and follow-up. AJR Am J Roentgenol 162:1191-1198, 1994